To this end, researchers have conducted a computational study to determine the neurobiological basis for the association between SARS-CoV-2 infections and MAO-B in Parkinson’s disease and Alzheimer’s disease, with the goal of identifying the novel molecule that simultaneously targets SARS-CoV-2 and MAO-B in order to mitigate the neurological disorder that ensues from the virus. This evidence concerns the gene MAOB and nervous system disorder.